We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Bigger needle

24 April 2017 By Robert Cyran

Becton Dickinson’s deal for C.R. Bard involves cost cuts worth less than half the 25 pct premium. Like lawmakers, though, U.S. healthcare firms are stuck with Obamacare’s pressures. Scale brings negotiating power needed to sell needles and catheters to consolidating hospitals.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)